Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page history now shows Revision: v3.6.6 added, indicating an update to the record's revision version (replacing v3.6.5). This reflects an administrative change to the record's history rather than any change to study data or content.SummaryDifference0.1%

- Check19 days agoChange DetectedA new history entry on 2026-07-24 adds a Terminated status with a Business Reason and updates Study/Recruitment Status. The prior Completed entry from 2025-10-15 is removed.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe history shows the record updated to revision v3.6.5, replacing the previous v3.6.4. This indicates a new version of the page was published.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the history, updating the page's version label. This is a metadata change and does not modify core trial information or user-facing content.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, replacing the previous revision (v3.6.0) to reflect an update to the page's version metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.